Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study

BMC Cardiovascular Disorders
Nahid Hashemi MadaniReza Malekzadeh

Abstract

Whether pre-diabetes in the absence of hypertension (HTN) or dyslipidemia (DLP) is a risk factor for occurrence of major adverse cardiovascular events (MACE) is not fully established. We investigated the effect of impaired fasting glucose (IFG) alone and in combination with HTN, DLP or both on subsequent occurrence of MACE as well as individual MACE components. This longitudinal population-based study included 11,374 inhabitants of Northeastern Iran. The participants were free of any cardiovascular disease at baseline and were followed yearly from 2010 to 2017. Cox proportional hazard models were fitted to measure the hazard of IFG alone or in combination with HTN and DLP on occurrence of MACE as the primary endpoint. Four hundred thirty-seven MACE were recorded during 6.2 ± 0.1 years follow up. IFG alone compared to normal fasting glucose (NFG) was not associated with an increase in occurrence of MACE (HR, 0.87; 95% CI, 0.19-4.02; p, 0.854). However, combination of IFG and HTN (HR, 2.88; 95% CI, 2.04-4.07; p, 0.000) or HTN + DLP (HR, 2.98; 95% CI, 1.89-4.71; p, 0.000) significantly increased the risk for MACE. Moreover, IFG + DM with or without HTN, DLP, or both was also associated with an increase in the incidence of MACE. IF...Continue Reading

References

Feb 15, 2001·Archives of Internal Medicine·UNKNOWN DECODE Study Group, the European Diabetes Epidemiology Group.
Oct 16, 2002·Circulation·David J Lefer
Mar 27, 2003·Journal of Hypertension·C M M LawesUNKNOWN Asia Pacific Cohort Studies Collaboration
Nov 11, 2008·The New England Journal of Medicine·Paul M RidkerUNKNOWN JUPITER Study Group
Apr 1, 2009·International Journal of Epidemiology·Akram PourshamsReza Malekzadeh
Mar 27, 2010·Journal of the American College of Cardiology·Earl S FordChaoyang Li
Apr 4, 2012·Indian Journal of Endocrinology and Metabolism·Jamshed J DalalAshish Gulati
Aug 26, 2014·Circulation·Elizabeth SelvinJosef Coresh
May 12, 2016·Genetic Testing and Molecular Biomarkers·Zhouqing HuangWeijian Huang
Nov 9, 2016·Current Atherosclerosis Reports·Jessica HurtubiseJoseph Fomusi Ndisang
Nov 14, 2016·JAMA : the Journal of the American Medical Association·Roger ChouThomas L Jeanne
Dec 17, 2016·Diabetes Care·UNKNOWN American Diabetes Association
Apr 28, 2017·European Journal of Preventive Cardiology·Nahid Hashemi MadaniAmeneh Ebrahimi Valojerdi
Jul 14, 2017·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Yukako Tatsumi, Takayoshi Ohkubo
Aug 27, 2017·Diabetes/metabolism Research and Reviews·Juan J GagliardinoEduardo Spinedi
Dec 15, 2017·BioMed Research International·Dou HuangCharbel Abi Khalil
Aug 16, 2018·The New England Journal of Medicine·Aidin RawshaniSoffia Gudbjörnsdottir
Feb 15, 2017·Cardiovascular Endocrinology·Haider J Warraich, Jamal S Rana

❮ Previous
Next ❯

Citations

Jan 23, 2021·International Journal of Environmental Research and Public Health·Purum KangKa Young Kim
Jul 3, 2021·International Journal of Molecular Sciences·Elena BarbuSerban-Mihai Balanescu

❮ Previous
Next ❯

Software Mentioned

Stata

Related Concepts

Related Feeds

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

Canadian Medical Association Journal
Canadian Medical Association Journal
The New England Journal of Medicine
J L Pinkus
The New England Journal of Medicine
A B Mason
The New England Journal of Medicine
G X Trimble
© 2021 Meta ULC. All rights reserved